Your genes could change your prescription. So why aren't doctors testing?

A study from the University of Pittsburgh reveals that nearly one in four patients are prescribed medications that may be ineffective or require dosage adjustments based on their genetic profile. Researchers suggest that integrating genetic testing into standard care could significantly reduce the trial-and-error approach to prescribing drugs.
Why it matters
Widespread adoption of pharmacogenomics could improve patient safety and treatment efficacy by personalizing medicine based on individual DNA.
A study published Wednesday in Science Translational Medicine found that nearly one in four participants had been prescribed a medication that could have required a different drug or dose based on their genetics.
The study, led by researchers at the University of Pittsburgh, examined 16 genes that affect how the body responds to medications.
DNA samples from 98,590 people in the National Institutes of Health's All of Us Research Program were analyzed and linked to participants' medical records when available.
Each carried at least one relevant genetic variation that could affect how their body responds to certain medications, with a typical participant carrying nine. Among those with both genetic and clinical data, 24.4 per cent had been prescribed at least one medication that, based on their genes, guidelines suggest should have been replaced with another drug or given a different dose.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in